SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
The daughter of a Covid-19 patient cries in front of Dhaka Medical College in Bangladesh on January 31, 2022. (Photo: Syed Mahamudur Rahman/NurPhoto via Getty Images)
WHO Says Covid Still Killing 'Far, Far Too Many' as Pharma Hoards Vaccine Tech
"Increasing deaths for six weeks in a row is not the situation we should be in right now," said WHO epidemiologist Dr. Maria Van Kerkhove.
Feb 17, 2022
Experts from the World Health Organization said Wednesday that global coronavirus deaths remain stunningly high two years into the pandemic as highly contagious variants--including Omicron and its relative--continue to circulate and possible new mutations loom.
"At this point in the pandemic, when we have tools that can save people's lives, this is far, far too many."
Dr. Maria Van Kerkhove, an infectious disease epidemiologist who serves as the WHO's Covid-19 technical lead, said during an event that this week is the "sixth week in a row that we're seeing increasing reports of deaths" from the coronavirus even as cases appear to be moving downward in parts of the globe, prompting some rich countries to begin easing public health restrictions.
Van Kerkhove cautioned world leaders against viewing the seeming decline in infections as evidence that the pandemic is on its way out, noting that the trend could be due to a precipitous drop in testing following the initial Omicron surge, which pushed recorded cases to new highs.
Emphasizing the alarming rise in deaths in recent days, Van Kerkhove noted that "almost 75,000 people died" of Covid-19 over the past week alone. According to figures from Johns Hopkins University, the coronavirus is killing more than 10,300 people each day on average.
"We know that is an underestimate," Van Kerkhove continued. "There is variation across the world in terms of increasing and decreasing cases and deaths. But at this point in the pandemic, when we have tools that can save people's lives, this is far, far too many. The big worry, really, is this increasing trend."
"Increasing deaths for six weeks in a row is not the situation we should be in right now," she added.
Given that Covid-19 death rates are far higher among the unvaccinated, the WHO has emphasized the importance of ensuring equitable distribution of vaccine doses worldwide.
But major pharmaceutical companies have thus far refused to take part in WHO-backed technology transfer efforts, denying developing countries the tools necessary to produce vaccines for their populations and leaving billions of people without access to lifesaving shots.
Just 10.6% of people in low-income countries have received at least one coronavirus vaccine dose, according to Our World in Data. If inequities persist, the WHO has warned, Africa may not be able to achieve 70% vaccination against Covid-19 until late 2024.
On Wednesday, the German company BioNTech announced a new plan to deliver mobile coronavirus vaccine factories to Africa in a purported effort to ramp up production on the continent. While the head of the WHO welcomed the initiative, critics argued that it reeks of a ploy by BioNTech to secure its grip on its vaccine recipe--which was developed with substantial public funding--and undercut Africa's ongoing efforts to independently manufacture mRNA shots.
In December, public health experts identified more than 100 firms in Africa and elsewhere across the Global South that currently have the capacity to produce coronavirus vaccines. All that's needed, according to experts, is a transfer of vaccine technology and manufacturing processes that pharmaceutical companies and rich nations have thus far withheld.
"After a year of stalling efforts to scale up global vaccine production, BioNTech's pop-up vaccine factories are little more than a neo-colonial stunt to try and maintain control of this lifesaving technology in Africa," said Tim Bierley, pharma campaigner at the U.K.-based advocacy group Global Justice Now. "This is inexcusable when we know there are several factories in Africa with the capacity to create these kinds of vaccines today, if BioNTech and others were willing to share the tech in this global emergency."
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Experts from the World Health Organization said Wednesday that global coronavirus deaths remain stunningly high two years into the pandemic as highly contagious variants--including Omicron and its relative--continue to circulate and possible new mutations loom.
"At this point in the pandemic, when we have tools that can save people's lives, this is far, far too many."
Dr. Maria Van Kerkhove, an infectious disease epidemiologist who serves as the WHO's Covid-19 technical lead, said during an event that this week is the "sixth week in a row that we're seeing increasing reports of deaths" from the coronavirus even as cases appear to be moving downward in parts of the globe, prompting some rich countries to begin easing public health restrictions.
Van Kerkhove cautioned world leaders against viewing the seeming decline in infections as evidence that the pandemic is on its way out, noting that the trend could be due to a precipitous drop in testing following the initial Omicron surge, which pushed recorded cases to new highs.
Emphasizing the alarming rise in deaths in recent days, Van Kerkhove noted that "almost 75,000 people died" of Covid-19 over the past week alone. According to figures from Johns Hopkins University, the coronavirus is killing more than 10,300 people each day on average.
"We know that is an underestimate," Van Kerkhove continued. "There is variation across the world in terms of increasing and decreasing cases and deaths. But at this point in the pandemic, when we have tools that can save people's lives, this is far, far too many. The big worry, really, is this increasing trend."
"Increasing deaths for six weeks in a row is not the situation we should be in right now," she added.
Given that Covid-19 death rates are far higher among the unvaccinated, the WHO has emphasized the importance of ensuring equitable distribution of vaccine doses worldwide.
But major pharmaceutical companies have thus far refused to take part in WHO-backed technology transfer efforts, denying developing countries the tools necessary to produce vaccines for their populations and leaving billions of people without access to lifesaving shots.
Just 10.6% of people in low-income countries have received at least one coronavirus vaccine dose, according to Our World in Data. If inequities persist, the WHO has warned, Africa may not be able to achieve 70% vaccination against Covid-19 until late 2024.
On Wednesday, the German company BioNTech announced a new plan to deliver mobile coronavirus vaccine factories to Africa in a purported effort to ramp up production on the continent. While the head of the WHO welcomed the initiative, critics argued that it reeks of a ploy by BioNTech to secure its grip on its vaccine recipe--which was developed with substantial public funding--and undercut Africa's ongoing efforts to independently manufacture mRNA shots.
In December, public health experts identified more than 100 firms in Africa and elsewhere across the Global South that currently have the capacity to produce coronavirus vaccines. All that's needed, according to experts, is a transfer of vaccine technology and manufacturing processes that pharmaceutical companies and rich nations have thus far withheld.
"After a year of stalling efforts to scale up global vaccine production, BioNTech's pop-up vaccine factories are little more than a neo-colonial stunt to try and maintain control of this lifesaving technology in Africa," said Tim Bierley, pharma campaigner at the U.K.-based advocacy group Global Justice Now. "This is inexcusable when we know there are several factories in Africa with the capacity to create these kinds of vaccines today, if BioNTech and others were willing to share the tech in this global emergency."
Experts from the World Health Organization said Wednesday that global coronavirus deaths remain stunningly high two years into the pandemic as highly contagious variants--including Omicron and its relative--continue to circulate and possible new mutations loom.
"At this point in the pandemic, when we have tools that can save people's lives, this is far, far too many."
Dr. Maria Van Kerkhove, an infectious disease epidemiologist who serves as the WHO's Covid-19 technical lead, said during an event that this week is the "sixth week in a row that we're seeing increasing reports of deaths" from the coronavirus even as cases appear to be moving downward in parts of the globe, prompting some rich countries to begin easing public health restrictions.
Van Kerkhove cautioned world leaders against viewing the seeming decline in infections as evidence that the pandemic is on its way out, noting that the trend could be due to a precipitous drop in testing following the initial Omicron surge, which pushed recorded cases to new highs.
Emphasizing the alarming rise in deaths in recent days, Van Kerkhove noted that "almost 75,000 people died" of Covid-19 over the past week alone. According to figures from Johns Hopkins University, the coronavirus is killing more than 10,300 people each day on average.
"We know that is an underestimate," Van Kerkhove continued. "There is variation across the world in terms of increasing and decreasing cases and deaths. But at this point in the pandemic, when we have tools that can save people's lives, this is far, far too many. The big worry, really, is this increasing trend."
"Increasing deaths for six weeks in a row is not the situation we should be in right now," she added.
Given that Covid-19 death rates are far higher among the unvaccinated, the WHO has emphasized the importance of ensuring equitable distribution of vaccine doses worldwide.
But major pharmaceutical companies have thus far refused to take part in WHO-backed technology transfer efforts, denying developing countries the tools necessary to produce vaccines for their populations and leaving billions of people without access to lifesaving shots.
Just 10.6% of people in low-income countries have received at least one coronavirus vaccine dose, according to Our World in Data. If inequities persist, the WHO has warned, Africa may not be able to achieve 70% vaccination against Covid-19 until late 2024.
On Wednesday, the German company BioNTech announced a new plan to deliver mobile coronavirus vaccine factories to Africa in a purported effort to ramp up production on the continent. While the head of the WHO welcomed the initiative, critics argued that it reeks of a ploy by BioNTech to secure its grip on its vaccine recipe--which was developed with substantial public funding--and undercut Africa's ongoing efforts to independently manufacture mRNA shots.
In December, public health experts identified more than 100 firms in Africa and elsewhere across the Global South that currently have the capacity to produce coronavirus vaccines. All that's needed, according to experts, is a transfer of vaccine technology and manufacturing processes that pharmaceutical companies and rich nations have thus far withheld.
"After a year of stalling efforts to scale up global vaccine production, BioNTech's pop-up vaccine factories are little more than a neo-colonial stunt to try and maintain control of this lifesaving technology in Africa," said Tim Bierley, pharma campaigner at the U.K.-based advocacy group Global Justice Now. "This is inexcusable when we know there are several factories in Africa with the capacity to create these kinds of vaccines today, if BioNTech and others were willing to share the tech in this global emergency."
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.